SHIKARI® S-ATC

Enzyme immunoassay for the qualitative determination of free Cetuximab (Erbitux®) in serum and plasma.

Cetuximab (Erbitux®) was associated to the development of anti- Cetuximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Erbitux®. This might lead to severe complications. The Matriks Biotek SHIKARI® Antibody to Cetuximab ELISA Kit can be efficiently used for monitoring anti- Cetuximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Cetuximab antibodies.

SHIKARI® S-ATCv2

Enzyme immunoassay for the quantitative determination of antibodies to cetuximab (Erbitux®) in serum and plasma

Cetuximab (Erbitux®) was associated to the development of anti- Cetuximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Erbitux®. This might lead to severe complications. The Matriks Biotek SHIKARI® Antibody to Cetuximab ELISA Kit can be efficiently used for monitoring anti- Cetuximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Cetuximab antibodies.